Company performance
Add to research
Current Price
as of Mar 20, 2025$0.26
P/E Ratio
N/A
Market Cap
$23.3M
Description
Add to research
Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air and Beyond Cancer segments. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
Metrics
Add to research
Overview
- HQGarden City, NY
- SectorHealth Technology
- IndustryMedical Specialties
- TickerXAIR
- Price$0.2639-4.52%
Trading Information
- Market cap$23.30M
- Float87.12%
- Average Daily Volume (1m)1,393,027
- Average Daily Volume (3m)1,773,783
- EPS-$1.05
Company
- Revenue$3.02M
- Rev growth (1yr)174.17%
- Net income-$13.03M
- Gross margin-20.06%
- EBITDA margin-941.79%
- EBITDA-$10.10M
- EV$31.85M
- EV/Revenue10.54
- P/EN/A
- P/S7.69
- P/B1.11
- Debt/Equity60.75
Documents
Add to research
SEC Filings
Factset Street Account
Earnings Calls
Factset